Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
Mirae Asset TIGER KOSDAQ150 Biotech ETF (261070 KS)
Watchlist
7
Analysis
South Korea
Mirae Asset TIGER KOSDAQ150 Biotech ETF is an exchange traded fund established in South Korea. The ETF's objective is to provide investment returns that corresponds closely to the performance of the KOSDAQ 150 Bio Technology sector index.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Macroeconomics
•
12 Nov 2020 15:04
Korea - Not Out Of The Woods
Korea may have returned to growth in the third quarter but the economy is not out of the woods. Job losses are mounting while companies remain...
Sharmila Whelan
363 Views
Share
bearish
•
Macroeconomics
•
04 Sep 2020 15:47
Korea - BoK Growth Scenarios
The Korean economy is slowly recovering from the Covid-19 shock but the outlook is uncertain. The central bank is decidedly bearish – forecast...
Sharmila Whelan
327 Views
Share
bearish
•
Macroeconomics
•
24 Apr 2020 06:59
Korea - Moon's Easy Wins, Hard Battles
Korea’s ruling coalition government swept this month’s national assembly elections and President Moon’s approval ratings have soared on the back of...
Sharmila Whelan
329 Views
Share
bearish
•
Macroeconomics
•
06 Jun 2019 11:26
Korean Won - Asia's Worst Performer In 2019
We bearish about Korea’s economic growth prospects this year and are underweight Korean equities in our relative regional portfolio. Add to this...
Sharmila Whelan
651 Views
Share
bearish
•
Macroeconomics
•
15 Apr 2019 16:16
Korea Interest Rates - Next Move Down
We expect interest rates will be declining by the end of the year. BoK Governor Lee Ju-yeol is running out of excuses not to ease monetary policy....
Sharmila Whelan
804 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.1
x